Zambia launches portable digital x-rays guidelines
Kennedy Lishimpi, permanent secretary for technical services at the Ministry of Health, said the lack of standardized national guidelines has led to inconsistencies in usage, safety protocols, and regulatory compliance.
"These guidelines will ensure that the use of portable x-ray technology aligns with national policy, global best practices, and safety standards, while enhancing efficiency across health facilities," Lishimpi said at the launch.
He noted that with the increasing demand for flexible and rapid diagnostic imaging solutions, portable digital X-ray units have become a game-changer, particularly in the management of tuberculosis, trauma, and other critical conditions.
According to Lishimpi, the introduction of the new guidelines will facilitate the broader use of portable digital X-ray units, promoting more equitable access to diagnostic services throughout the country.
He called for the full implementation and integration of the guidelines into national health systems to ensure all Zambians can benefit.
The government, he emphasized, remains committed to improving access to quality diagnostic services at all levels of care, especially in hard-to-reach and underserved communities.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
5 hours ago
- The Star
Japan discards state-acquired Covid-19 drugs worth US$1.6bil
TOKYO: (Bernama-Kyodo) The Japanese government discarded Covid-19 oral medicines believed to be worth around 240 billion yen (US$1.6 billion) in the fiscal year through March as they had passed their expiry dates, Kyodo News Agency reported, citing health ministry officials on Wednesday (July 16). While the exact purchase price remains unclear, the value was calculated in accordance with current prices. The amount is enough to treat some 2.5 million people. The government acquired the oral drugs at the height of the coronavirus pandemic and provided them free of charge to hospitals and clinics nationwide. But many of them were unused after Covid-19 was downgraded to the same category as seasonal influenza in May 2023, which required people to pay for Covid-19 treatment. Drugmakers had also started general distribution of Covid-19 medicine in Japan themselves. A Ministry of Health, Labour and Welfare official said offering the drugs to other countries was considered but legally difficult. Among the two million doses of Pfizer Inc.'s nirmatrelvir and 1.6 million doses of Merck & Co.'s molnupiravir procured by the government, about 1.75 million doses of nirmatrelvir and some 780,000 doses of molnupiravir were disposed of, according to the ministry. The government also secured two million doses of Shionogi & Co.'s ensitrelvir but about 1.77 million of them are unused, the ministry said. They are expected to be discarded after they reach their expiration dates starting next fiscal year. - Bernama-Kyodo
The Star
6 hours ago
- The Star
Laos urges vigilance as dengue risk rises amid persistent rainfall
VIENTIANE (Xinhua): As persistent rainfall continues across Laos, health authorities urge the public to remain alert and take preventive measures against dengue fever. Although Laos has reported a significant drop in dengue cases, health officials caution that the risk remains high during the rainy season. They urge residents to participate in local clean-up efforts and practice home prevention measures to combat the spread of the disease. To further prevent dengue, local officials in many villages have organized collective activities that encourage authorities and villagers to work together to eliminate mosquito breeding sites around their homes. Mithouna, a Vientiane resident, actively participates in local clean-up efforts. "My neighbours and I clean our homes and surroundings at least once a week. Everyone needs to work together to reduce the risk of dengue fever, especially during continuous rainfall," Mithouna told Xinhua on Sunday. She stressed that dengue affects entire communities, not just individuals. "Dengue is a deadly disease, and it doesn't affect just one household. That's why I believe everyone needs to stay alert and take responsibility." Chanxay emphasized the importance of disease prevention, especially during the current period of continuous rainfall when many children are home on summer break. "The rain hasn't stopped, and water is collecting everywhere. On top of that, children are home from school, which makes this a very dangerous time for us," said Chanxay. "As parents, we have to be more careful than ever." As of July 21, Laos has reported 4,308 cases of dengue fever, including one death. The highest number of cases was recorded in the Lao capital Vientiane, which reported 2,052 infections, according to the Ministry of Health. Health authorities recommend five effective dengue control measures for households, sealing unused containers, emptying water vessels, placing guppy fish in jars to consume mosquito larvae, cleaning around homes, and consistently performing these tasks weekly. - Xinhua
Sinar Daily
9 hours ago
- Sinar Daily
Research explains why promising cancer treatments trigger serious side effects
SYDNEY - Research is shedding new light on the causes of serious side effects linked to some promising cancer treatments, reported Xinhua. Scientists have discovered that the protein MCL-1, a key target in cancer drug development, plays not only a role in preventing cell death in cancer cells but also supplying energy to normal cells, according to a statement released Tuesday by Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne. As a result, drugs that inhibit MCL-1 can inadvertently damage healthy tissues that rely on this protein for energy, especially in organs with high energy demand like the heart and liver, leading to the severe side effects observed in clinical trials, WEHI said. The new findings clarify that these side effects may be linked to the protein's critical role in cellular energy production, which enables the development of safer, more targeted cancer therapies that reduce harm to healthy tissues while staying effective against cancer. "If we can direct MCL-1 inhibitors preferentially to tumour cells and away from the cells of the heart and other healthy tissues, we may be able to selectively kill cancer cells while sparing healthy tissues," said the study's co-senior researcher Andreas Strasser, a WEHI laboratory head. The study, published in Science, also paves the way for safer combination therapies by enabling smarter dosing and pairing of MCL-1 inhibitors with other treatments to reduce toxicity. - BERNAMA-XINHUA
